Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Skinvisible Inc (SKVI)

Skinvisible Inc (SKVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 459
  • Shares Outstanding, K 4,540
  • Annual Sales, $ 280 K
  • Annual Income, $ -1,220 K
  • 60-Month Beta -0.41
  • Price/Sales 11.48
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SKVI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.39
  • Most Recent Earnings $-0.07 on 04/16/24
  • Latest Earnings Date 05/08/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0610 unch
on 04/22/24
0.1010 -39.60%
on 04/12/24
-0.0200 (-24.69%)
since 03/21/24
3-Month
0.0610 unch
on 04/22/24
0.1020 -40.20%
on 03/13/24
-0.0090 (-12.86%)
since 01/19/24
52-Week
0.0550 +10.91%
on 01/10/24
0.1399 -56.40%
on 06/14/23
-0.0409 (-40.14%)
since 04/12/23

Most Recent Stories

More News
Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New Drug

LAS VEGAS, NV / ACCESSWIRE / June 6, 2022 / Skinvisible, Inc. ("Skinvisible") (OTCQB:SKVI), is pleased to announce that its licensee Quoin Pharmaceuticals, Inc. ("Quoin") (NASDAQ:QNRX), has received U.S....

SKVI : 0.0610 (-39.60%)
QNRX : 0.6600 (-7.03%)

Business Summary

SKINVISIBLE PHARMACEUTICALS Inc., a wholly owned subsidiary of Skinvisible Inc., is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare to pharmaceutical and cosmeceutical companies as well as assisting companies in revitalizing...

See More

Key Turning Points

3rd Resistance Point 0.0610
2nd Resistance Point 0.0610
1st Resistance Point 0.0610
Last Price 0.0610
1st Support Level 0.0610
2nd Support Level 0.0610
3rd Support Level 0.0610

See More

52-Week High 0.1399
Fibonacci 61.8% 0.1075
Fibonacci 50% 0.0975
Fibonacci 38.2% 0.0874
Last Price 0.0610
52-Week Low 0.0550

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar